|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology 显示文摘 | Ludovini V Pistola L Gregorc V | 2008 | J Thorac Oncol2008，3，4： | 1 |
| 2 | Plasma DNA,microsatellite alterations,and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients:a study of the perugia multidisciplinary team for thoracic oncology显示文摘 | Ludovini V Pistola L Gregorc V | 2008 | J Thorac Oncol2008，3，4： | 1 |
| 3 | Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages Ⅰ and Ⅱ breast cancer patients 显示文摘 | Ludovini V Sidoni A Pistola L | 2003 | Breast Cancer Res Treat2003，81，2： | 1 |
| 4 | High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients显示文摘 | Ludovini V Bellezza G Pistola L | 2009 | Ann Oncol2009，20，： | 1 |
| 5 | VEGF and S100 beta serum levels in advanced non-small cell lung cancer (NSCLC)patients with and without brain metastases(BM)at diagnosis显示文摘 | V Ludovini L Pistola | 2005 | Eur J Cancer Supplements2005，3，2： | 1 |
| 6 | Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer显示文摘 | Ludovini V Gregorc V Pistola L | 2004 | Lung Cancer2004，46，： | 1 |
| 7 | Phosphoinositide-3 Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhihitors in Patients with Advanced Non-small Cell Lung Cancer显示文摘 | Ludovini V Bianconi F Pistola L | | 0，，： | 1 |
| 8 | Influence of serum vascular endothelial growth factor (VEGF) and haemoglobin (Hb) levels on survival of non-small cell lung cancer patients (NSCLC)显示文摘 | Gregorc V Ludovini V Pistola L | 2002 | Ann Oncol2002，13，3： | 1 |
| 9 | Vascular endothelial growth factor,p53,Rb,Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer显示文摘 | Gregorc V Pistola L | 2004 | Lung Cancer2004，46，： | 1 |
| 10 | High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients 显示文摘 | LUDOVINI V BELLEZZA G PISTOLA L | 2009 | Ann Oncol2009，20，5： | 1 |
| 11 | Phosphoinositide-3-ki-nase catalytic alpha and KRAS mutations are important predictorsof resistance to therapy with epidermal growth factor receptor tyro-sine kinase inhibitors in patients with advanced non-small celllung cancer显示文摘 | Ludovini V Bianconi F Pistola L | 2011 | J Thorac Oncol2011，6，4： | 1 |
| 12 | High coexpression of both insulin-like growth factor receptor 1 (1GFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease free survival in resected non-small-cell lung cancer patients 显示文摘 | Ludovini V Bellezza G Pistola L | 2009 | Ann Oncol2009，20，5： | 1 |
| 13 | High coexpression of both insulin-like growth factor receptor-I (IGFR-1) and epider- mal growth factor receptor (EGFR) is associated with shorter disease free survival in resected non-small-cell lung cancer pa- tients显示文摘 | Ludovini V Bellezza G Pistola L | 2009 | Ann Oncol2009，20，5： | 1 |
| 14 | High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free surviv- al in resected non-small-cell lung cancer patients显示文摘 | Ludovini V Bellezza G Pistola L | 2009 | Ann Oncol2009，20，5： | 1 |
| 15 | Plasma DNA,microsatellite alterations,and p53tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients:a study of the perugia multidisciplinary team for thoracic oncology显示文摘 | Ludovini V Pistola L Gregorc V | 2008 | J Thoraco ncol2008，3，4： | 1 |
| 16 | Optimization of patient se-lection for EGFR - TKIs in advanced non - small - cell lung canc-er by combined analysis of MET,EGFR,KRAS,and PIK3 CA mu-tations 显示文摘 | Ludovini V Bianconi F Pistola L | 2010 | J Clinl Oncol2010，2，8： | 1 |
| 17 | Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients 显示文摘 | Ludovini V Sidoni A Pistola L | 2003 | Breast Cancer Res Treat2003，81，2： | 1 |
| 18 | Serum level changes of matrix metalloproteinases 2 and 9 ,vascular endothelial growth factor and epidermal factor receptor during platinum-based chemotherapy in advanced non- small cell lung cancer patients 显示文摘 | Mihaylova Zh Ludovini V Gregorg V Floriani I Pistola L Toffaneti F | 2007 | J BUON2007，12，1： | 1 |
| 19 | Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer 显示文摘 | Ludovini V Bianconi F Pistola L | 2011 | J Thoracic Oncol2011，6，4： | 1 |
| 20 | Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages Ⅰ and Ⅱ breast cancer patients 显示文摘 | Ludovini V Sidoni A Pistola L | 2003 | Breast Cancer Res Treat2003，81，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员